NCT04952051View on ClinicalTrials.gov

Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

July 31, 2019

Study Completion Date

July 1, 2020

Conditions
Hypertension
Interventions
DRUG

Enalapril Folic Acid Tablets Combined With amlodipine

Enalapril Folic Acid Tablets 10.8mg Combined With amlodipine 5 or 10mg

DRUG

Enalapril Folic Acid Tablets Combined With hydrochlorothiazide

Enalapril Folic Acid Tablets 10.8mg Combined With hydrochlorothiazide 12.5 or 25mg

Trial Locations (1)

310009

Second affiliated Hospital Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
collaborator

National Clinical Research Center, Southern Medical University

UNKNOWN

collaborator

Ningbo Yinzhou Community Health Service Center

UNKNOWN

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT04952051 - Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension | Biotech Hunter | Biotech Hunter